Systemic cancer therapy with a small molecule agonist of toll-like receptor 7 can be improved by circumventing TLR tolerance (Q84422615)
Jump to navigation
Jump to search
scientific article published on 22 June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Systemic cancer therapy with a small molecule agonist of toll-like receptor 7 can be improved by circumventing TLR tolerance |
scientific article published on 22 June 2011 |
Statements
Systemic cancer therapy with a small molecule agonist of toll-like receptor 7 can be improved by circumventing TLR tolerance (English)
Christian Hotz
Daniel Noerenberg
Andreas Voelkl
Simon Heidegger
Laurin C Roetzer
Bettina Storch
Nadja Sandholzer
Cornelia Wurzenberger